Stage III Cervical Cancer Completed Phase 1 Trials for Trastuzumab (DB00072)

Also known as: Cervical cancer stage III / Cervix uteri cancer stage III / Carcinoma uterine cerix stage III / Cervical carcinoma stage III / Carcinoma uterine cervix stage III / Cervix carcinoma stage III / Ca cervix stage III / Carcinoma cervix stage III

IndicationStatusPhase
DBCOND0028824 (Stage III Cervical Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment